EICHORPublic-registry trials using Tocilizumab biosimilar that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006) | Merck Sharp & Dohme LLC | Chronic Lymphocytic Leukaemia | PHASE2 | 0 |
| First registered study | October 2013 — NCT01965132 (Seoul National University Hospital) |
| Registered studies matching this name | 12 all-time · 5 currently recruiting |
Source: ClinicalTrials.gov, the public trial registry.
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Trialed alongside
Other Chronic Lymphocytic Leukaemia drugs
← Eichor home · All tracked trials · Chronic Lymphocytic Leukaemia studies · Weekly briefs
